UBS Maintains Buy on Alkermes, Raises Price Target to $48

Benzinga Newsdesk www.benzinga.com Positive 79.8%

Neg 0% Neu 0% Pos 79.8%

UBS analyst Ashwani Verma maintains Alkermes (NASDAQ:ALKS) with a Buy and raises the price target from $42 to $48.

Comments

No comments yet. Be the first!